EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Colon-Targeted Mucoadhesive PLGA Microspheres Loaded with Ramulus Mori Alkaloids for Enhanced Water-Soluble Drug Delivery in Ulcerative Colitis Treatment

Mo Wang, Yu Jiang, Zhiyang Chen, Dengbao Jiang, Xuan Jiang, Jun Ye, Hongliang Wang iD, Yuling Liu

Molecules · 23.04.2025 · 30 (9) · 1878

DOI: 10.3390/molecules30091878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 23.04.2025. Verfasst von Mo Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Pek…. Hauptthemen laut MEDLINE: Microspheres, Colitis, Ulcerative, Polylactic Acid-Polyglycolic Acid Copolymer, Alkaloids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences (CIFMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammation disease with severe impact on quality of life, with limited treatment options. Ramulus Mori alkaloids (SZ-A) from Morus alba show promise for UC treatment due to their safety and pharmacological effects, including anti-inflammation and barrier repair. However, their clinical use has been limited by gastrointestinal flatulence as a side effect due to their pharmacological action as an α-glucosidase inhibitor targeting the small intestine following oral administration. Therefore, constructing a colon-targeted formulation to deliver SZ-A is an advantageous strategy to improve UC therapy. In this study, we used the complex formed by thiolated hyaluronic acid, which has mucosal adhesion and inflammation-targeting properties, and SZ-A as an intermediate carrier and prepared sodium alginate-modified PLGA microspheres (SZ-A@MSs) with the double emulsion method to achieve efficient encapsulation of SZ-A. Specifically, sodium alginate serves as a gastric acid protectant and microbiota-responsive material, enabling the precise and responsive release of microspheres in the colonic region. SZ-A@MSs have a particle size of about 30 µm, a drug loading of about 12.0%, and an encapsulation efficiency of about 31.7% and function through intestinal adhesion to and targeting of inflammatory sites. SZ-A@MSs showed antioxidant and anti-inflammatory abilities in Raw264.7 cells. In vivo imaging results suggest that SZ-A@MSs have good colon site retention and sustained-release effect. Pharmacodynamic results show that SZ-A@MSs display good efficacy, including the ability to inhibit weight loss, inhibit colonic atrophy, and inhibit the secretion of inflammatory factors. In conclusion, SZ-A@MSs have good colon-targeting properties, can improve therapeutic effects, and provide a potential treatment method for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrospheresColitis, UlcerativePolylactic Acid-Polyglycolic Acid CopolymerAlkaloidsDrug Delivery SystemsColonAnimalsMiceDrug CarriersSolubilityAlginatesWaterIntestinal MucosaDrug LiberationParticle SizeAnti-Inflammatory AgentsDisease Models, AnimalMale

Stichwörter der Autor:innen

PLGARamulus Mori alkaloidsanti-inflammatorymicrosphereulcerative colitis

Substanzen

Polylactic Acid-Polyglycolic Acid CopolymerAlkaloidsDrug CarriersAlginatesWaterAnti-Inflammatory Agents

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
  • School of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • University-Town Hospital of Chongqing Medical University, Chongqing 401331, China.

ORCID-Profile: Hongliang Wang

Förderung

  • CAMS Innovation Fund for Medical Sciences (CIFMS)

Zitieren

APA

Wang, M., Jiang, Y., Chen, Z., Jiang, D., Jiang, X., Ye, J., Wang, H., & Liu, Y. (2025). Colon-Targeted Mucoadhesive PLGA Microspheres Loaded with Ramulus Mori Alkaloids for Enhanced Water-Soluble Drug Delivery in Ulcerative Colitis Treatment. Molecules, 30(9), 1878. https://doi.org/10.3390/molecules30091878

Vancouver

Wang M, Jiang Y, Chen Z, Jiang D, Jiang X, Ye J, et al. Colon-Targeted Mucoadhesive PLGA Microspheres Loaded with Ramulus Mori Alkaloids for Enhanced Water-Soluble Drug Delivery in Ulcerative Colitis Treatment. Molecules. 2025;30(9):1878. doi:10.3390/molecules30091878

BibTeX
@article{Wang2025,
  author = {Wang, Mo and Jiang, Yu and Chen, Zhiyang and Jiang, Dengbao and Jiang, Xuan and Ye, Jun and Wang, Hongliang and Liu, Yuling},
  title = {Colon-Targeted Mucoadhesive PLGA Microspheres Loaded with Ramulus Mori Alkaloids for Enhanced Water-Soluble Drug Delivery in Ulcerative Colitis Treatment},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {9},
  pages = {1878},
  doi = {10.3390/molecules30091878}
}
Kostenlos starten →